Product Images Topiramate

This text provides detailed information about Topiramate capsules containing 15 mg of Topiramate, USP. It includes instructions for dosage, storage conditions, and precautions. The product should be dispensed in a tight container, stored at 20° to 25°C with permitted excursions, protected from moisture, and kept out of children's reach. A Medication Guide and Package Insert are available online. The NDC number for the capsules is 72888-228-12. The capsules are distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Pvt. Ltd. This information is specifically meant for pharmacists to dispense along with each patient's medication guide.*

This is a description of topiramate capsules with each capsule containing 15mg of topiramate. It provides information on dosage, prescribing instructions, storage conditions, and a link to the Medication Guide and Package Insert. The capsules should be kept in a tight container at temperatures between 20°C to 25°C, with excursions permitted to 15°C to 30°C. The product is distributed by Advagen Pharma Ltd. in the USA and manufactured by Rubicon Research Pvt. Ltd. in India. Pharmacies are instructed to dispense the Medication Guide to each patient, and the full prescribing information is available online at the provided web address.*

This text provides information about a medication called Topiramate in capsule form with a concentration of 15mg. It also includes details about the manufacturer, storage instructions, and a link for additional product literature. The medication should be kept in a tight container at a temperature range of 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). It emphasizes protection from moisture, keeping it out of reach of children, and directs to consult a pharmacist for further guidance. Additionally, it mentions the availability of a Medication Guide and Package Insert. The product literature can be found on the website provided.*

Each capsule of Topiramate USP contains 15 mg. The medication guide and package insert are available online. The capsules should be stored in a tight container at 20° to 25°C, with excursions permitted to 15° to 30°C. It is important to protect the capsules from moisture and keep them out of reach of children. Pharmacists are instructed to dispense the medication guide to each patient. The product is distributed by Advagen Pharma Ltd. in the USA and manufactured by Rubicon Research Pvt. Ltd. in India. Additionally, the NDC number and prescribing information are provided for identification and guidance.*

Each capsule of Topiramate USP contains 15mg. It is recommended to store the capsules in a tight container at temperatures between 20°C to 25°C (68°F to 77°F). The medication should be protected from moisture and kept out of reach of children. The pharmacist should dispense the accompanying Medication Guide to each patient. This medication is distributed by Advagen Pharma Ltd., East Windsor, NJ, and manufactured by Rubicon Research Pvt. Ltd., Thane, India. The product information and package insert are available online at the provided website.*

This text provides information on Topiramate capsules containing 25 mg of USP. It includes details on dosage, prescribing information, storage conditions, and protection from moisture. The product is dispensed in a tight container and should be stored at a specified temperature range. Additionally, there are instructions to keep the medication out of reach of children, a reference to the Medication Guide available online, and details about distribution and manufacturing. The text also mentions the NDC number, pharmacist instructions, and other relevant information.*

This text provides information about Topiramate capsules, each containing 25 mg of Topiramate, USP. It includes instructions on dosage, storage, dispensing, and protection from moisture. The medication guide and package insert can be accessed online. The capsules are distributed by Advagen Pharma Ltd. in East Windsor, NJ, USA, and manufactured by Rubicon Research Pvt. Ltd. in Thane, India. Pharmacies are instructed to dispense the medication guide to each patient.*

This text provides details about topiramate capsules containing 25 mg of topiramate. It includes instructions for storage, prescribing information, and a medication guide link for patients. The capsules are dispensed in a tight container and should be stored at a temperature range of 20° to 25°C. The product is distributed by Advagen Pharma Ltd. in the USA and manufactured by Rubicon Research Pvt. Ltd. in India. Pharmacists are advised to dispense the Medication Guide to each patient. The NDC number for the product is 72888-229-30.*

Each capsule contains 25 mg of Topiramate, USP. It is important to follow the dosage and prescribing information provided in the accompanying product literature. The capsules should be stored in a tight container at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). They need to be protected from moisture and kept out of reach of children. The Medication Guide and Package Insert are available online. Pharmacists should dispense the Medication Guide to each patient. This medication is available in a container of 500 capsules and is distributed by Advagen Pharma Ltd., USA, and manufactured by Rubicon Research Pvt. Ltd., India.*

This text describes a medication called Topiramate in capsule form, with each capsule containing 25 mg of Topiramate, USP. The text provides instructions for dosage, storage, and protection from moisture. It also mentions the necessity to dispense the medication in a tight container and includes a website link for the Medication Guide and Package Insert. Additionally, it specifies the distribution and manufacturing details of the medication.*

This text provides information about Topiramate capsules containing 0mg of Topiramate, USP. It includes instructions for dosage, storage, dispensing, and availability of detailed product information online. The capsules should be stored in a tight container at 20° to 25°C, with excursions permitted to 15° to 30°C. The medication guide and package insert are available on the website provided. The product is distributed by Advagen Pharma Ltd. in the USA and manufactured by Rubicon Research Pvt. Ltd. in India. The text also includes details for pharmacists on dispensing the medication guide to each patient.*

This text provides information about a medication called Topiramate in capsule form, each containing 50 mg of the active ingredient. It also includes details on storage conditions, dosage instructions, and how to dispense the product. The medication guide and package insert are available online, and the product is distributed by Advagen Pharma Ltd. in the USA and manufactured by Rubicon Research Pvt. Ltd. in India.*

This is a description of Topiramate Capsules, USP containing 50 mg of Topiramate per capsule. The text provides instructions for dosage, storage, and dispensing the medication in a tight container at controlled room temperature. It also includes information on protecting from moisture, keeping out of reach of children, and provides a link to access the Medication Guide and Package Insert. The product is manufactured by Rubicon Research Pvt. Ltd., India, and distributed by Advagen Pharma Ltd., USA. Pharmacist instruction included dispensing the Medication Guide to each patient.*

This text provides information about Topiramate capsules containing 50 mg of Topiramate, USP. It includes details for dosage, storage, and safety precautions such as keeping out of reach of children. Additionally, the text mentions a Medication Guide and Package Insert available online. The product is distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Pvt. Ltd. The NDC number provided is 72888-230-60. Pharmacist's instructions are also mentioned.*

This section presents Cumulative Rates for Time to First Seizure at different dosage levels of Topiramate over a span of 500 days. The chart shows the trend of seizure occurrence over time for two groups receiving different doses of Topiramate, 50mg/day, and 400mg/day.*

This text provides information on the change from baseline to the double-blind phase in the average monthly migraine period rate for Topiramate and Placebo at different doses. Topiramate at 100mg/day and 200mg/day showed statistically significant differences compared to Placebo (p<0.010 and p<0.001 respectively).*